Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aeropak is an Italian contract development and manufacturing organization (CDMO) specializing in the production of pharmaceutical aerosols and pressurized metered-dose inhalers (pMDIs). The company provides comprehensive services ranging from formulation development and stability testing to large-scale commercial manufacturing and packaging. Aeropak operates state-of-the-art facilities that comply with global Good Manufacturing Practice (GMP) standards, serving major pharmaceutical clients worldwide. Their expertise primarily focuses on respiratory health, delivering treatments for conditions such as asthma and chronic obstructive pulmonary disease (COPD). By leveraging specialized filling technologies, Aeropak ensures high-precision dosing and product reliability for complex pulmonary drug delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aeropak.